Impact of rifampicin addition to clarithromycin in Legionella pneumophila pneumonia
- 1 September 2006
- journal article
- research article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 28 (3) , 249-252
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Clinical Outcomes for Hospitalized Patients with Legionella Pneumonia in the Antigenuria Era: The Influence of Levofloxacin TherapyClinical Infectious Diseases, 2005
- Treatment of Legionnaires??? DiseaseDrugs, 2005
- Update of Practice Guidelines for the Management of Community-Acquired Pneumonia in Immunocompetent AdultsClinical Infectious Diseases, 2003
- Legionnaires' disease: a rational approach to therapyJournal of Antimicrobial Chemotherapy, 2003
- Clinical Pharmacokinetics of ClarithromycinClinical Pharmacokinetics, 1999
- Evaluation of the Drug Interaction Between Clarithromycin and RifampinJournal of Infectious Disease Pharmacotherapy, 1997
- Comparison of bronchopulmonary pharmacokinetics of clarithromycin and azithromycinAntimicrobial Agents and Chemotherapy, 1996
- Reduced Serum Levels Of Clarithromycin In Patients Treated With Multi-Drug Regimens Including Rifampin Or Rifabutin For Mycobacterium Avium-M. Intracellulare InfectionThe Journal of Infectious Diseases, 1995
- Comparison of the activity of three antibiotic regimens in severe Legionnaires' diseaseJournal of Antimicrobial Chemotherapy, 1990